NVIDIA Top Inception Showcase 2026 — one of ten life-science startups selected

Accelerating Drug Discovery with AI

Chaparral Discovery

The AI platform for drug discovery

Turn proteomics and multi-omics data into therapeutic targets, biomarkers, and actionable insights.

Currently available for early partnerships and enterprise evaluation. Reach out through the Contact page to learn more.

In the press: San Diego Business Journal — “Chaparral Labs using AI to find better drug targets” →

Used by researchers at

Scripps Research
UC San Diego
UC Berkeley
Duke University
Northwestern University
Cedars Sinai
Light Horse Therapeutics
3D BioAnalitiX
Stealth Peptide Therapeutics
Korea University
Mayo Clinic
What We Do

Chaparral Discovery

One platform that turns proteomics and multi-omics data into actionable drug discovery insights.

Chaparral Discovery

A unified drug discovery environment that integrates reprocessed omics data, public databases, scientific literature, and a knowledge graph into one AI-powered platform.

Target & Biomarker Discovery

Apply established AI and machine learning methods to proteomics, metabolomics, and multi-omics data to identify therapeutic targets and biomarkers.

Evidence-Backed Insights

Every result is traceable to reprocessed data, public databases, or literature — giving drug discovery teams confidence in every hypothesis.

Engine for the Platform

A Bioinformatics Foundation for AI

Garbage in, garbage out. Chaparral Discovery is built on a rigorous bioinformatics foundation of deep, accurate proteomics data analysis — the bedrock every AI model needs to deliver trustworthy discovery insights.

Deep Proteome Coverage

Rigorous data acquisition analysis that captures deep, accurate proteome coverage.

Targeted Quantification

Precise, targeted quantitative analysis for reliable, reproducible measurements.

Scalable Data Processing

Machine learning-driven analysis pipelines built for scalable proteomics data.

From Data to Discovery

How the Platform Works

1

Quality-Controlled Data

Proteomics, metabolomics, and multi-omics data are processed through rigorous bioinformatics engines to ensure accuracy and reproducibility.

2

Knowledge Graph

Entities, relationships, and evidence are structured in a Neo4j knowledge graph connecting proteins, pathways, diseases, drugs, and literature.

3

AI-Powered Insights

Predictive modeling, target prioritization, and drug repositioning analysis identify high-confidence targets and biomarkers.

4

Actionable Discovery

Evidence-backed hypotheses feed into therapeutic programs, partnered research, and enterprise evaluation workflows.

See Chaparral Discovery in Action

Tell us about your discovery challenge. We'll schedule a call to show you how the platform works for your research.